Navigation Links
Stem Cell Markets - New Market Report
Date:11/5/2013

Value Chain of Mesenchymal Stem Cell Therapeutics 265
Figure A1.2: Use of Coverage and Reimbursement Knowledge in the Product Life Cycle 266
Figure A2.1: Eye Tissues Being Targeted for Stem Cell Replacement 278
Figure A2.2: Human Stem Cell Sources Explored for Eye Tissue Replacement 278
Figure A4.1: Public vs. Private Regenerative Medicine Companies, 2013 285
Figure A4.2: RM Sector Investment Breakdown, 2013 286
Figure A4.3: Comparison of S&P to Underweighted Regenerative Medicine Index, March 2012-
March 2013 286
Figure A4.4: Comparison of NASDAQ to Underweighted Regenerative Medicine Index, March 2012-
March 2013 287

INDEX OF TABLES

Table 3.1: Stem Cells Isolated from Embryonic or Adult Sources 35
Table 4.1: U.K. Cell Therapy Clinical Trials, 2012 and 2013 55
Table 5.1: NIH Stem Cell Research Funding, 2002-2012 58
Table 5.2: CIRM Stem Cell Research in Progress 61
Table 5.3: CIRM’s Therapy Development Projects 63
Table 5.4: CIRM Funding for Huntington’s Disease, 2013 67
Table 5.5: CIRM Funding Heart Diseases, 2013 67
Table 5.6: CIRM Grants Targeting HIV/AIDS 69
Table 5.7: Stem Cell Research Funding in the State of Connecticut, 2013 70
Table 7.1: Currently Available Cell Therapy Products 81
Table 9.1: Cell Therapies Available by Geography/Country, March 2013 118
Table 9.2: Key Industry Parameters: Tissue Engineering and Stem Cell Therapeutics, 2007 and 2011 123
Table 9.3: Sales of Commercial Tissue Engineering and Stem Cell Products, 2011 124
Table 9.4: Partial List of Firms Supporting Stem Cell Industry 131
Table 10.1: Industry-Sponsored Active Cell Therapy Clinical Trials, 2007 and 2012 139
Table 10.2: Market Capitalization of Stem Cell Companies, 2011 and 2012 143
Table 10.3: Stem Cell Therapy in Ophthalmology by Application as of April 2013 154
Table 11.1: Select
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine news :

1. Biosimulation Market (For Drug Discovery & Development) Worth $1.2 Billion by 2017 - New Report by MarketsandMarkets
2. Geosynthetics Market (Geotextile, Geomembrane, Geogrid, Geofoam, Geonet) Volume Worth 5.6 Billion Meter Square by 2018 - New Report by MarketsandMarkets
3. Customer Experience Management Market (Network Types, Touch Points, Verticals) Worth $6.61 Billion by 2017 - New Report by MarketsandMarkets
4. Bring-Your-Own-Device Market (Mobile Device Management, Mobile Application Management) Worth $181.39 Billion by 2017 - New Report by MarketsandMarkets
5. Pressure Sensor Market (Piezoresistive, Capacitive, Electromagnetic, Resonant Solid State, Optical) Worth $7.34 Billion by 2017 - New Report by MarketsandMarkets
6. Breast Imaging Technologies Market (Digital Mammography, 3D Breast Tomosynthesis, Breast MRI) Worth $5 Billion - 2017 - New Report by MarketsandMarkets
7. Biofuels (Bioethanol & Biodiesel) Production in Top and Emerging Countries will be 150,975 Million Liters in 2016 - New Report by MarketsandMarkets
8. Acoustic Wave Sensor Market (SAW And BAW) Worth $721.13 Million - Global Forecast by 2018 - New Report by MarketsandMarkets
9. Cloud Radio Access Network (CLOUD RAN) Market (Components and Services) worth $11.31 Billion by 2018 - New Report by MarketsandMarkets
10. Infection Control Market (Sterilization and Disinfection) Worth $14.0 Billion by 2017- New Report by MarketsandMarkets
11. Aqua Feed Market (Antibiotics, Vitamins, Antioxidants, Amino Acids, Feed Enzymes, Feed Acidifiers) Worth $106 Billion By 2018 - New Report by MarketsandMarkets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 2014 Julie Kuriakose, MD; ... , will discuss how restaurants can become more allergy-friendly ... dietary restrictions at the 2014 Allergy Eats Food ... October 21 in New York City. , “I’m extremely ... to such an engaged industry audience. As food allergies ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 In ... well as better data capture and management functions ... ClinCapture electronic data capture (EDC) system. ClinCapture offers ... ability to easily manage clinical trial data and ... cement Synergy’s position as the leading clinical research ...
(Date:9/30/2014)... From October 12-15, MMS, Inc. (Medical ... SHSMD Connections Annual Conference in San Diego, California. ... Development (SHSMD) is proud to host the event of ... and strategic planning professionals in San Diego this fall: ... conference is a four-day event designed to equip ...
(Date:9/30/2014)... Bibliomotion is proud to announce the release of ... Social Age by Frank Guglielmo and Sudhanshu ... authors apply their leadership coaching experience to introduce Social Leadership ... and behaviors that leaders must adopt in order to thrive ... read a review of The Social Leader in Dialogue Reviews. ...
(Date:9/30/2014)... JACKSON, Tenn. (PRWEB) September 30, 2014 ... Oct. 4, from 10 a.m. to 2 p.m. at ... Pinson). Woodmen of the World sponsors this family-oriented festival, ... free, and the festival will feature a car show, ... climbing wall, hayride and children’s games. Also, Lightning McQueen ...
Breaking Medicine News(10 mins):Health News:Hudson Allergy’s Dr. Julie Kuriakose to Speak at Prestigious Food Allergy Conference in New York City 2Health News:Hudson Allergy’s Dr. Julie Kuriakose to Speak at Prestigious Food Allergy Conference in New York City 3Health News:Synergy Research Group Opts for Clinovo 2Health News:Synergy Research Group Opts for Clinovo 3Health News:MMS, Inc. (Medical Marketing Service) to Attend the 2014 SHSMD Connections Annual Conference in October 2Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 2Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 3Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 4Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 5Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 6
... coverage and other problems persist, analysis shows, , WEDNESDAY, July ... access to prescription drug coverage has ballooned since Medicare,s Part ... new analysis finds, yet seniors, ability to pay for needed ... rising drug plan costs. , "Based on nearly four years ...
... in the regulation of cell death has been identified ... led them to recommend caution when drugs called IAP ... liver conditions. , A team led by Professor Andreas ... has found that XIAP (X-chromosome-linked inhibitor of apoptosis protein) ...
... , Presidential Health Advisor , s Writings Support ... DALLAS, July 22 On the cusp of President Obama,s news conference tonight, ... care reform plan may result in denying care to a significant number of ... Administration does not consider doctors the best judges of the type of health ...
... WEDNESDAY, July 22 (HealthDay News) -- One part of the ... when deadly plaque builds up, but two other sections don,t, ... Wake Forest University Baptist Medical Center have found. , ... and left carotid arteries expands by 11 percent, on average, ...
... , , LANTANA, Fla., July ... (IHPA), announced today the launching of the , ... Get the Number , campaign is an ... for when buying storm and hurricane protection," Johnston said. "Consumers ...
... , , OAK BROOK, ... gastroenterologists, gastroenterology nurses and gastroenterology fellows, announces enhanced site content ... , , NAAP describes the ... of a physician, or by a physician or nurse other ...
Cached Medicine News:Health News:Medicare Drug Plan Still Needs Work 2Health News:Medicare Drug Plan Still Needs Work 3Health News:Critical link in cell death pathway revealed 2Health News:NCPA: White House Has Ideas on How to Ration Health Care 2Health News:Carotid Artery Sections React Differently to Plaque 2Health News:IHPA Launches Consumer Awareness Campaign for Hurricane Protection 2Health News:IHPA Launches Consumer Awareness Campaign for Hurricane Protection 3Health News:SedationFacts.org Presents Content on Policies and Conditions Regarding Alternative Methods for the Administration of Propofol 2Health News:SedationFacts.org Presents Content on Policies and Conditions Regarding Alternative Methods for the Administration of Propofol 3Health News:SedationFacts.org Presents Content on Policies and Conditions Regarding Alternative Methods for the Administration of Propofol 4
(Date:9/30/2014)... 2014  Come fall, many children, teenagers, and even ... want to be for Halloween. And, a number of ... contact lenses bought without a prescription. Halloween, ... purchase and wear contact lenses without a prescription. According ... consumer survey, 17 percent of Americans have worn ...
(Date:9/30/2014)... Sept. 30, 2014 CytRx Corporation (NASDAQ: ... development company specializing in oncology, today announced the ... evaluating aldoxorubicin compared to topotecan in subjects with ... relapsed or were refractory to prior chemotherapy. Aldoxorubicin ... agent, doxorubicin. CytRx has received Orphan Drug Designation ...
(Date:9/29/2014)... and DUBLIN , Sept. ... or the "Company"), a biotechnology company pioneering the manufacturing ... of innovative therapies for cancer, HIV/AIDS, opportunistic infections and ... its shareholders from CEO Noreen Griffin The letter follows: ... (the "Company" or "TNIB") received a number of calls ...
Breaking Medicine Technology:The Spooky Truth: What You Need To Know About Contact Lens Hygiene 2The Spooky Truth: What You Need To Know About Contact Lens Hygiene 3CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of Relapsed/Refractory Small Cell Lung Cancer 2CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of Relapsed/Refractory Small Cell Lung Cancer 3CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of Relapsed/Refractory Small Cell Lung Cancer 4CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of Relapsed/Refractory Small Cell Lung Cancer 5TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 2TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 3TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 4TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 5TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 6TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 7TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 8
... VIEJO, Calif., May 14, 2012  Bausch + Lomb, ... Barr Global President of the company,s Surgical business.  ... full suite of ophthalmic surgical products, intraocular lenses ... names as enVista™ Crystalens®, Stellaris® ...
... N.Y., May 14, 2012   Pharmaceutical manufacturers and ... requiring reporting on drug product samples distribution using XML, ... To help the pharmaceutical industry cope with the ... for ongoing Standard SPL filings, Data Conversion Laboratory (DCL) ...
Cached Medicine Technology:Bausch + Lomb Names John Barr Global President Surgical 2Bausch + Lomb Names John Barr Global President Surgical 3Coping With New FDA Mandates For Drug Sample Distribution 2
0.25 mm diameter textured tip with protective guard....
... for perfect focus where it's needed - ... along with Keeler's wide angle light beam ... patient's pupil size, you will see the ... technology provides a longer life battery and ...
... for perfect focus where it's needed - ... along with Keeler's wide angle light beam ... patient's pupil size, you will see the ... technology provides a longer life battery and ...
... individually adjusted for perfect focus where it's ... paper. This, along with Keeler's wide angle ... whatever the patient's pupil size, you will ... view. Lithium-ion technology provides a longer life ...
Medicine Products: